Pitchkit
  • Docs
  • Pricing
  • Blog
  • Tools
  • Investors
Sign inGet started
Pitchkit

Structure and stress-test your pitch with workflows built from 6+ years of VC dealflow.

Product

  • Overview
  • Pitch deck feedback
  • Pitch deck generator
  • Templates
  • Pricing

Resources

  • Learn
  • Pitch by stage
  • Slide guides
  • Docs
  • Glossary
  • Free tools

Company

  • About
  • Blog
  • Changelog
  • Contact
  • Privacy policy

Ready to pitch?

Start building your investor-ready pitch today. Free forever, no credit card required.

Start free

© 2026 Pitchkit / edgelord.tech

All systems operational
Pitchkit
Back to investor directory
Venture capital
United Kingdom

Dementia Discovery Fund

Investment focus

Sectors

Biotech
Healthtech

Investment stages

Seed
Series A
Series B

Geographic focus

Europe
United States
Global

Investment thesis

Specialist neurodegeneration venture fund managed by SV Health Investors with pharma consortium backing (Biogen, Eli Lilly, GSK, Pfizer, Takeda, and Bill Gates), investing in disease-modifying therapeutics for Alzheimer's and other dementias.

Typical check size

€5M – €30M

Fund size: $269M (DDF-2)

Browse similar check sizes →

Portfolio highlights

Caraway Therapeutics - lysosomal biology neurodegeneration biotech; acquired by Merck for up to $610M
Cerevance - CNS drug discovery using human brain cell-type molecular profiling
Autifony Therapeutics - Kv3 potassium channel modulators for hearing and brain disorders

Contact

ddf.vc
United Kingdom

Research with AI

Learn more about Dementia Discovery Fund using AI:

Ask ChatGPTAsk Perplexity

Pitch guides

Learn what Dementia Discovery Fund and similar investors look for:

Biotech pitch guideHealthtech pitch guide

More investors in United Kingdom

20VC21506 Degrees Capital83NorthView all in United Kingdom

Related resources

Seed fundraising guideSeed pitch deck guideSeries A fundraising guideSeries A pitch deck guideSeries B fundraising guideGlossary: Term sheet
Fundraising in United Kingdom

Tips, programs, and cultural notes

More Biotech investors

AbingworthACF InvestorsAhren Innovation CapitalAlmi Invest GreenTechView all Biotech investors